Tirzepatide 5mg

Tirzepatide 5mg For Sale – Tirzepatide 5mg In Stock

Tirzepatide 5mg is a common, therapeutic, once-weekly subcutaneous maintenance or escalation dose of a dual GIP/GLP-1 receptor agonist (sold as Mounjaro for type 2 diabetes or Zepbound for weight loss). It works by enhancing insulin secretion, delaying gastric emptying, and reducing appetite to manage blood sugar and induce significant weight loss.

What is tirzepatide for weight loss?

Tirzepatide (Zepbound brand) is a once-weekly injection used for weight loss, weight management, and weight-related conditions, including obstructive sleep apnea (OSA). Tirzepatide works by reducing appetite, increasing the feeling of fullness, and slowing gastric emptying, which helps with weight loss.

Tirzepatide is a GIP and GLP-1 receptor agonist.

Tirzepatide is self-administered as a subcutaneous injection using a single-dose pen, multi-dose KwikPen, or a vial with a syringe, and should always be used alongside a healthy diet and regular exercise.

Tirzepatide (Zepbound) Keypoints

• FDA-approved for weight management for adults with obesity, or overweight patients with weight-related conditions
• Prescription medicine
• Once-weekly injection
• Average 22.5% body-weight reduction for tirzepatide (15mg) over 72 weeks
• Not for use in type 1 diabetes
• Common side effects: nausea, diarrhea, vomiting

Who can use tirzepatide for weight loss?

The Zepbound brand of tirzepatide is FDA-approved for:

• weight loss and weight reduction management in adults with
  • obesity, or
  • overweight and have weight-related medical condition(s)
• Severe obstructive sleep apnea (OSA) in adults with obesity.

Key Information for 5mg Dosage:

• Usage: Usually initiated after 4 weeks of the initial 2.5mg dose.
• Administration: Once weekly injection under the skin (stomach, thigh, or upper arm).
• Effectiveness: Studies show the 5mg dose is effective for weight loss and significant reductions in HbA1c (blood sugar levels) compared to placebo.
• Weight Loss Efficacy: In trials, a significant percentage of patients (approx. 85%) on 5mg lost at least 5% of their body weight.
• Side Effects: The most common side effects are gastrointestinal, including nausea, diarrhea, vomiting, constipation, and abdominal pain, particularly during dose increases.
• Warnings: It has a black box warning regarding potential thyroid C-cell tumors. It should not be used if you have a history of Medullary Thyroid Carcinoma (MTC)